##common.pageHeaderLogo.altText##

Original article

Vol. 155 No. 12 (2025)

Impact of the COVID-19 pandemic on routine childhood immunisation coverage and timeliness in Switzerland: a retrospective analysis using data from the Swiss National Vaccination Coverage Survey, 2019–2023

Cite this as:
Swiss Med Wkly. 2025;155:4525
Published
17.12.2025

Summary

BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has disrupted healthcare systems worldwide, leading to concerns about reduced access to routine childhood immunisations. However, comprehensive data on how the pandemic specifically impacted paediatric vaccination coverage in Switzerland remain limited across the country. The present study provides an analysis of the timeliness and coverage of routine childhood immunisations in Switzerland before and during the COVID-19 pandemic, offering insights into potential fluctuations in coverage.

AIMS: To assess the impact of the COVID-19 pandemic on routine childhood immunisation in Switzerland by comparing vaccination coverage and timeliness for children under 35 months of age before and during the pandemic. Additionally, the study seeks to identify factors associated with the likelihood of children receiving vaccinations, considering demographic and geographic variables.

METHODS: We used 2019–2023 data from the Swiss National Vaccination Coverage Survey (SNVCS), a cross-sectional survey that collected immunisation information of children under 35 months of age from a nationally representative sample of households. Children who were eligible for a vaccine from March 2020 to March 2021 were considered as the COVID-affected group and those eligible for a vaccine before this date were included in the pre-COVID-19 cohort. Coverage of the following vaccine doses was considered: diphtheria at one, two and three doses (Di1, Di2, Di3); pneumococcus at one, two and three doses (PCV1, PCV2, PCV3); and measles first and second dose (MCV1, MCV2). Vaccine timeliness was defined as receiving a dose on time with a tolerance period of 30 days. We used logistic regression models to identify and understand the factors that might influence vaccination rates.

RESULTS: For the diphtheria vaccines (Di1, Di2, Di3), while coverage remained high, there was a slight decrease observed in timely vaccination rates for some doses, with reductions of around 1% to 3% compared to pre-COVID-19 levels. The impact on PCV1, PCV2 and PCV3 showed similar trends, with slight reductions in coverage during the pandemic, but these differences were not statistically significant. For measles-containing vaccines (MCV1 and MCV2), coverage during the pandemic was higher compared to pre-COVID-19 rates. Geographic and demographic factors, such as an urban setting, nationality and linguistic region, significantly influence childhood vaccination rates in Switzerland.

CONCLUSION: While minor declines in vaccine timeliness were observed (diphtheria vaccine, pneumococcal conjugate vaccine), the overall likelihood of vaccination was not significantly affected by the COVID-19 pandemic. However, changes in vaccination recommendations introduced in 2019 may have influenced these trends.

References

  1. 1. Castrejon MM, Leal I, de Jesus Pereira Pinto T, Guzmán-Holst A. The impact of COVID-19 and catch-up strategies on routine childhood vaccine coverage trends in Latin America: A systematic literature review and database analysis. Hum Vaccin Immunother. 2022 Nov;18(6):2102353. 10.1080/21645515.2022.2102353
  2. 2. Dalton M, Sanderson B, Robinson LJ, Homer CS, Pomat W, Danchin M, et al. Impact of COVID-19 on routine childhood immunisations in low- and middle-income countries: A scoping review. PLOS Glob Public Health. 2023 Aug;3(8):e0002268. 10.1371/journal.pgph.0002268
  3. 3. Causey K, Fullman N, Sorensen RJ, Galles NC, Zheng P, Aravkin A, et al. Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study. Lancet. 2021 Aug;398(10299):522–34. doi: https://doi.org/10.1016/S0140-6736(21)01337-4
  4. 4. Ghaznavi C, Eguchi A, Suu Lwin K, Yoneoka D, Tanoue Y, Kumar Rauniyar S, et al. Estimating global changes in routine childhood vaccination coverage during the COVID-19 pandemic, 2020-2021. Vaccine. 2023 Jun;41(28):4151–7. 10.1016/j.vaccine.2023.05.034
  5. 5. Unicef: COVID-19 pandemic leads to major backsliding on childhood vaccinations. 2021. Available from: https://www.unicef.org/press-releases/covid-19-pandemic-leads-major-backsliding-childhood-vaccinations-new-who-unicef-data
  6. 6. Shet A, Carr K, Danovaro-Holliday MC, Sodha SV, Prosperi C, Wunderlich J, et al. Impact of the SARS-CoV-2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories. Lancet Glob Health. 2022 Feb;10(2):e186–94. doi: https://doi.org/10.1016/S2214-109X(21)00512-X
  7. 7. National Centre for Immunisation Research and Surveillance. Impact of COVID-19 on School-based Vaccination Programs Module 1, 2 & 3: Final report. 2023. Available from: https://ncirs.org.au/sites/default/files/2023-04/COVID%20impact%20on%20schools_Final%20report_April%202023.pdf
  8. 8. SeyedAlinaghi S, Afsahi AM, MohsseniPour M, Behnezhad F, Salehi MA, Barzegary A, et al. Late Complications of COVID-19; a Systematic Review of Current Evidence. Arch Acad Emerg Med. 2021 Jan;9(1):e14. 10.22037/aaem.v9i1.1058
  9. 9. Ogundele OA, Omotoso AA, Fagbemi AT. COVID-19 outbreak: a potential threat to routine vaccination programme activities in Nigeria. Hum Vaccin Immunother. 2021 Mar;17(3):661–3. 10.1080/21645515.2020.1815490
  10. 10. Bundesamt für Gesundheit und Eidgenössische Kommission für Impffragen. Schweizerischer Impfplan 2025. Available from: https://www.bag.admin.ch/bag/de/home/gesund-leben/gesundheitsfoerderung-und-praevention/impfungen-prophylaxe/schweizerischer-impfplan.html
  11. 11. Bundesamt für Gesundheit: Kantonales Durchimpfungsmonitoring Schweiz Available from: https://www.bag.admin.ch/bag/de/home/gesund-leben/gesundheitsfoerderung-und-praevention/impfungen-prophylaxe/schweizerischer-impfplan.html [accessed 18 July 2025]
  12. 12. Lang P, Zimmermann H, Piller U, Steffen R, Hatz C: The Swiss National Vaccination Coverage Survey, 2005-2007. Public Health Rep 2011, 126 Suppl 2(Suppl 2):97-108. doi: https://doi.org/10.1177/00333549111260S212
  13. 13. Luman ET, Barker LE, Shaw KM, McCauley MM, Buehler JW, Pickering LK. Timeliness of childhood vaccinations in the United States: days undervaccinated and number of vaccines delayed. JAMA. 2005 Mar;293(10):1204–11. 10.1001/jama.293.10.1204
  14. 14. Baroutsou V, Wymann M, Zens K, Sinniger P, Fehr J, Lang P. National and regional variations in timely adherence to recommended measles vaccination scheme in 2-years old in Switzerland, 2005-2019. Vaccine. 2022 May;40(22):3055–63. 10.1016/j.vaccine.2022.04.008
  15. 15. Akmatov MK, Kretzschmar M, Krämer A, Mikolajczyk RT. Timeliness of vaccination and its effects on fraction of vaccinated population. Vaccine. 2008 Jul;26(31):3805–11. 10.1016/j.vaccine.2008.05.031
  16. 16. Wariri O, Utazi CE, Okomo U, Metcalf CJ, Sogur M, Fofana S, et al. Mapping the timeliness of routine childhood vaccination in The Gambia: A spatial modelling study. Vaccine. 2023 Sep;41(39):5696–705. 10.1016/j.vaccine.2023.08.004
  17. 17. Kiely M, Boulianne N, Talbot D, Ouakki M, Guay M, Landry M, et al. Impact of vaccine delays at the 2, 4, 6 and 12 month visits on incomplete vaccination status by 24 months of age in Quebec, Canada. BMC Public Health. 2018 Dec;18(1):1364. 10.1186/s12889-018-6235-6
  18. 18. Lumley T. Analysis of Complex Survey Samples. J Stat Softw. 2004;9(8):1–19. 10.18637/jss.v009.i08
  19. 19. Bundesamt für Raumplanung. Die sieben Grossregionen der Schweiz Die Schweiz im europäischen Regionalsystem. 1999. Available from: https://www.admin.ch/gov/de/start/dokumentation/medienmitteilungen.msg-id-10585.html
  20. 20. Bramer CA, Kimmins LM, Swanson R, Kuo J, Vranesich P, Jacques-Carroll LA, et al. Decline in Child Vaccination Coverage During the COVID-19 Pandemic - Michigan Care Improvement Registry, May 2016-May 2020. MMWR Morb Mortal Wkly Rep. 2020 May;69(20):630–1. 10.15585/mmwr.mm6920e1
  21. 21. Santoli JM, Lindley MC, DeSilva MB, Kharbanda EO, Daley MF, Galloway L, et al. Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration - United States, 2020. MMWR Morb Mortal Wkly Rep. 2020 May;69(19):591–3. 10.15585/mmwr.mm6919e2
  22. 22. Ackerson BK, Sy LS, Glenn SC, Qian L, Park CH, Riewerts RJ, et al. Pediatric Vaccination During the COVID-19 Pandemic. Pediatrics. 2021 Jul;148(1):e2020047092. 10.1542/peds.2020-047092
  23. 23. Teasdale CA, Borrell LN, Shen Y, Kimball S, Zimba R, Kulkarni S, et al. Missed routine pediatric care and vaccinations in US children during the first year of the COVID-19 pandemic. Prev Med. 2022 May;158:107025. 10.1016/j.ypmed.2022.107025
  24. 24. Bonanni P, Bergamini M. Factors influencing vaccine uptake in Italy. Vaccine. 2001 Oct;20 Suppl 1:S8–12. 10.1016/S0264-410X(01)00284-5
  25. 25. Bundesamt für Gesundheit: Anpassung des Impfplans für Säuglinge und Kinder bis 2 Jahre: Zusammenfassung und praktische Umsetzung. https://www.infovac.ch/docs/public/-main/anpassung-des-impfplans-fu--r-sa--uglinge-und-kinder-bis-2-jahre--zusammenfassung-und-praktische-umsetzung.pdf
  26. 26. Bundesamt für Gesundheit. Versorgungsengpass bei Impfstoffen: Ersatzempfehlungen für die Impfung gegen Masern, Mumps und Röteln (MMR). 2019. Available from: https://www.bag.admin.ch/dam/bag/de/dokumente/mt/i-und-b/impfstoffversorgung/vergangen/lieferunterbruch-mmr.pdf.download.pdf/lieferunterbruch-mmr-de.pdf
  27. 27. Freeman RE, Leary CS, Graham JM, Albers AN, Wehner BK, Daley MF, et al. Geographic proximity to immunization providers and vaccine series completion among children ages 0-24 months. Vaccine. 2023 Apr;41(17):2773–80. 10.1016/j.vaccine.2023.03.025
  28. 28. Albers AN, Thaker J, Newcomer SR. Barriers to and facilitators of early childhood immunization in rural areas of the United States: A systematic review of the literature. Prev Med Rep. 2022 Apr;27:101804. doi: https://doi.org/10.1016/j.pmedr.2022.101804
  29. 29. Ménétrey A, Landolt MA, Buettcher M, Neuhaus TJ, Simma L. Vaccine Hesitancy in Central Switzerland: Identifying and Characterizing Undervaccinated Children in a Pediatric Emergency Department. Pediatr Rep. 2023 Dec;15(4):710–21. doi: https://doi.org/10.3390/pediatric15040064
  30. 30. Ammeter T, Lang P, Czock A. Overview of the influenza vaccination activities and legal frameworks in 26 Swiss cantons during the influenza season 2019/20. Vaccine. 2022 Mar;40(12):1702–6. 10.1016/j.vaccine.2022.02.009
  31. 31. Ruckstuhl L, Czock A, Haile SR, Lang P. Influence of cantonal health policy frameworks & activities on the influenza vaccination rate in patients with non-communicable diseases in Switzerland. Vaccine. 2022 Oct;40(44):6326–36. 10.1016/j.vaccine.2022.09.038
  32. 32. Riesen M, Konstantinoudis G, Lang P, Low N, Hatz C, Maeusezahl M, et al. Exploring variation in human papillomavirus vaccination uptake in Switzerland: a multilevel spatial analysis of a national vaccination coverage survey. BMJ Open. 2018 May;8(5):e021006. 10.1136/bmjopen-2017-021006
  33. 33. Lang P, Wu CT-S, Le-Nguyen AF, Czock A: Influenza Vaccination Behaviour of Healthcare Workers in Switzerland: A Cross-Sectional Study. Int J Public Health. 2023 Mar 10;68:1605175. 10.3389/ijph.2023.1605175
  34. 34. Oyewole OR, Lang P, Albrich WC, Wissel K, Leib SL, Casanova C, et al. The Impact of Pneumococcal Conjugate Vaccine (PCV) Coverage Heterogeneities on the Changing Epidemiology of Invasive Pneumococcal Disease in Switzerland, 2005-2019. Microorganisms. 2021 May;9(5):1078. doi: https://doi.org/10.3390/microorganisms9051078
  35. 35. Endrich MM, Blank PR, Szucs TD. Influenza vaccination uptake and socioeconomic determinants in 11 European countries. Vaccine. 2009 Jun;27(30):4018–24. 10.1016/j.vaccine.2009.04.029
  36. 36. Jary H, Pullen A, Howett D, Hani E, Suleman S, Byrne L, et al. Sociodemographic inequalities in the epidemiology and vaccine uptake within a large outbreak of measles in Birmingham, England, 2023 to 2024. Euro Surveill. 2025 Apr;30(16):2400652. 10.2807/1560-7917.ES.2025.30.16.2400652
  37. 37. Larson HJ, Jarrett C, Eckersberger E, Smith DM, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012. Vaccine. 2014 Apr;32(19):2150–9. 10.1016/j.vaccine.2014.01.081
  38. 38. Bundesamt für Gesundheit. Zahlen zu Infektionskrankheiten. 2024. Available from: https://www.bag.admin.ch/bag/de/home/zahlen-und-statistiken/zahlen-zu-infektionskrankheiten.exturl.html/aHR0cHM6Ly9tZWxkZXN5c3RlbWUuYmFnYXBwcy5jaC9pbmZyZX/BvcnRpbmcvZGF0ZW5kZXRhaWxzL2QvbWFzZXJuLmh0bWw_d2Vi/Z3JhYj1pZ25vcmU=.html
  39. 39. Torjesen I. Measles outbreaks likely as covid pandemic leaves millions of world’s children unvaccinated, WHO warns. BMJ. 2021 Nov;375(2755):n2755. 10.1136/bmj.n2755
  40. 40. European Centre for Disease Prevention and Control. Measles: Annual Epidemiological Report for 2023. 2024. Available from: https://www.ecdc.europa.eu/en/publications-data/measles-annual-epidemiological-report-2023
  41. 41. Centres for Disease Prevention and Control. Global Measles Outbreaks. 2024. Available from: https://www.cdc.gov/global-measles-vaccination/data-research/global-measles-outbreaks/index.html
  42. 42. Centres for Disease Prevention and Control. Increase in Global and Domestic Measles Cases and Outbreaks: Ensure Children in the United States and Those Traveling Internationally 6 Months and Older are Current on MMR Vaccination. 2023. Available from: https://emergency.cdc.gov/han/2024/han00504.asp
  43. 43. World Health Organization. European Region reports highest number of measles cases in more than 25 years –UNICEF, WHO/Europe. 2023. Available from: https://www.who.int/europe/news/item/13-03-2025-european-region-reports-highest-number-of-measles-cases-in-more-than-25-years---unicef--who-europe
  44. 44. Cassini A, Cobuccio L, Glampedakis E, Cherpillod P, Crisinel PA, Pérez-Rodríguez FJ, et al. Adapting response to a measles outbreak in a context of high vaccination and breakthrough cases: an example from Vaud, Switzerland, January to March 2024. Euro Surveill. 2024 May;29(22):2400275. 10.2807/1560-7917.ES.2024.29.22.2400275
  45. 45. Steffen R, Lautenschlager S, Fehr J. Travel restrictions and lockdown during the COVID-19 pandemic-impact on notified infectious diseases in Switzerland. J Travel Med. 2020 Dec;27(8):taaa180. 10.1093/jtm/taaa180
  46. 46. Brockhaus L, Urwyler P, Leutwyler U, Würfel E, Kohns Vasconcelos M, Goldenberger D, et al. Diphtheria in a Swiss Asylum Seeker Reception Centre: Outbreak Investigation and Evaluation of Testing and Vaccination Strategies. Int J Public Health. 2024 Apr;69:1606791. 10.3389/ijph.2024.1606791